SEE MORE Act

HR 6663, Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues S. 2020, SEE MORE ACT Vision Research Funding Medical Surprise Billing Legislative proposals HR 3107, Improving Seniors' Timely Access to Care Act HR 3975, Contact Lens Prescription Verification Modernization Act S. 4613, Contact Lens Rule Modernization Act HR 2279/S.2546, Safe Step Act HR 4665, The Medicare Vision Act HR 3, Elijah Cummings Lower Drug Cost Now Act Coronavirus Pandemic Relief Measures HR 6365/S.3559 Immediate Relief for Rural Facilities and Providers Act HR 7059, Coronavirus Provider Protection Act HR 2620, Faster Treatments and Cures for Eye Diseases Act HR 7819, Eliminating the Provider Relief Fund Tax Penalties Act S. 4295, Public Health Emergency Pass-Through Payment Fairness Act HR 8624, Protecting Access to Innovation During COVID-19 Act S.4932, the Medicare Reimbursement Equity Act HR 8702/S. 5007, the Holding Providers Harmless From Medicare Cuts During COVID-19 Act HR 8505, a bill to waive budget neutrality requirements of the Medicare Physician Fee Schedule H.R. 8709, the Analyzing Kinetic Impact Projectiles (KIPs) Against Americans Act

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act. Provider burden issues Medicare payment to physicians Drug pricing Covid-19 related issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act. Provider burden issues Medicare payment to physicians Drug pricing Covid-19 related issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 6663, Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues S. 2020, SEE MORE ACT Vision Research Funding Medical Surprise Billing Legislative proposals HR 3107, Improving Seniors' Timely Access to Care Act HR 3975, Contact Lens Prescription Verification Modernization Act HR 2279/S.2546, Safe Step Act HR 4665, The Medicare Vision Act HR 3, Elijah Cummings Lower Drug Cost Now Act Coronavirus Pandemic Relief Measures HR 6365/S.3559 Immediate Relief for Rural Facilities and Providers Act HR 7059, Coronavirus Provider Protection Act HR 2620, Faster Treatments and Cures for Eye Diseases Act HR 7819, Eliminating the Provider Relief Fund Tax Penalties Act S. 4295, Public Health Emergency Pass-Through Payment Fairness Act

Client expense: $200,000 · Firm income: Not reported

Reauthorization of the Public Private Partnership Advisory Council to End Human Trafficking (PPPAC); federal policy generally related to human trafficking issues; assistance with writing and editing the PPPAC's 2020 Report to Congress.

Client expense: Not reported · Firm income: Not reported

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act. Provider burden issues Medicare payment to physicians Drug pricing Covid-19 related issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 6663, Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues CREATES ACT, S.340 SEE MORE ACT, S.2020 Vision Research Funding Medical Surprise Billing Legislative proposals HR3107, Improving Seniors' Timely Access to Care Act HR3975, Contact Lens Prescription Verification Modernization Act HR2279/S.2546, Safe Step Act HR4665, The Medicare Vision Act HR3, Elijah Cummings Lower Drug Cost Now Act S.2723 Mitigating Emergency Drug Shortage Act (MEDS) Coronavirus Pandemic Relief Measures HR6365/S.3559 Immediate Relief for Rural Facilities and Providers Act HR7059, Coronavirus Provider Protection Act HR2620, Faster Treatments and Cures for Eye Diseases Act

Client expense: $240,000 · Firm income: Not reported

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act. Provider burden issues Medicare payment to physicians Drug pricing Covid-19 related issues

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues CREATES ACT, S.340 SEE MORE ACT, S.2020 Vision Research Funding Medical Surprise Billing Legislative proposals HR3107, Improving Seniors' Timely Access to Care Act HR3975, Contact Lens Prescription Verification Modernization Act HR2279/S.2546, Safe Step Act HR4665, The Medicare Vision Act HR3, Elijah Cummings Lower Drug Cost Now Act S.2723 Mitigating Emergency Drug Shortage Act (MEDS) Coronavirus Pandemic Relief Measures HR6365/S.3559 Immediate Relief for Rural Facilities and Providers Act HR3975 Contact Lens Prescription Verification Modernization Act

Client expense: $250,000 · Firm income: Not reported

Intangible Drilling Costs (IDCs); General Business Taxation Issues; the President's 2020 Budget; Administrative Oil and Gas Industry Tax rulemakings and official opinions

Client expense: $130,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues CREATES ACT, S.340 SEE MORE ACT, S.2020 Vision Research Funding Medical Surprise Billing Legislative proposals HR3107, Improving Seniors' Timely Access to Care Act HR3975, Contact Lens Prescription Verification Modernization Act HR2279/S.2546, Safe Step Act HR4665, The Medicare Vision Act HR3, Elijah Cummings Lower Drug Cost Now Act

Client expense: $240,000 · Firm income: Not reported

Supported getting a phaseout of PFAS and PFOS at military installations, regulating PFAS and PFOS under CERCLA, regulating both chemicals under the Safe Drinking Water Act, the Clean Water Act and TSCA. Supported S.1790, H.R.2500, H.R.1865, Senate's 2020 Water Resources Development Act, H.R.1497, and H.R.535

Client expense: $10,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Intangible Drilling Costs (IDCs); General Business Taxation Issues; the President's 2020 Budget; Administrative Oil and Gas Industry Tax rulemakings and official opinions

Client expense: $90,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

Access to Frontline Health Care Act, all sections Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues CREATES ACT, S.340 SEE MORE ACT, S.2020 Vision Research Funding Medical Surprise Billing Legislative proposals HR3107, Improving Seniors' Timely Access to Care Act Surprise Medical Billing Legislation HR3975, Contact Lens Prescription Verification Modernization Act

Client expense: $210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Physician fee schedule, Medicare reimbursement for ophthalmological services and devices, including S. 2020 the SEE More Act.

Client expense: Not reported · Firm income: Not reported

Access to Frontline Health Care Act, all sections Truth in Health Care Marketing Act P.L. 111-148 Affordable Care Act, modifications: 1. Reducing regulatory/costly burdens on medical practices - relief from regulatory burdens 2. Preserving patient access to office ancillary testing services Meaningful Use/EHR program issues P.L. 113-54, Drug Quality & Security Act, all sections Medicare Advantage plan network adequacy Prior authorization utilization policies Medicare Part B Drug Price Issues Medicare Access and CHIP Reauthorization Act (P.L. 114-10) Implementation Issues Proposed Contact Lens Rule Modifications Medicare Physician Payment Issues Drug Pricing and Shortages Issues CREATES ACT, S.340 SEE MORE ACT, S.2020 Vision Research Funding Medical Surprise Billing Legislative proposals HR3107, Improving Seniors' Access to Care Act

Client expense: $260,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Intangible Drilling Costs (IDCs); General Business Taxation Issues; the President's 2020 Budget; Administrative Oil and Gas Industry Tax rulemakings and official opinions

Client expense: $70,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

Intangible Drilling Costs (IDCs); General Business Taxation Issues; the President's 2020 Budget; Administrative Oil and Gas Industry Tax rulemakings and official opinions

Client expense: $260,000 · Firm income: Not reported

Government targets: Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE, Treasury, Dept of

National aviation policy; Federal Aviation Administration funding President's 2020 budget as related to aviation Airline performance and profitability Airline passenger issues, including passengers fees, passenger facility charges Issues related to the Dept. of Homeland Security and aviation security; TSA funding Aviation screening, including facial recognition technology Airline safety; air traffic controllers; funding for the ATC system War risk insurance; aviation emissions Aviation accident investigations; air certifications Nominations for Dept. of Transportation, National Transportation Safety Board, Federal Aviation Administration, Metropolitan Washington Airport Authority

Client expense: Not reported · Firm income: $30,000

Government targets: Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE

In support of the RAISE Health Benefits Act (S 503/HR 1366) - expanding the use of FSAs In support of the Health Savings Act (S 12) - expanding the use of HSAs Comments to the National Institutes of Health about the Surgeon General's 2020 Report on Oral HEalth

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE